Status:
COMPLETED
Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer
Lead Sponsor:
Chinese Academy of Medical Sciences
Conditions:
Locally Advanced Malignant Neoplasm
Eligibility:
FEMALE
18-70 years
Phase:
PHASE4
Brief Summary
For patients resistant to enthrycycline and taxanes, there is no standard regimen. Pemetrexed alone had certain efficacy in treatment of advance breast cancer. Platin was also a effective drug for adv...
Detailed Description
combination of pemetrexed and cisplatin to treat advanced breast cancer. Previous regimen no more than 3 which including enthrycycline and taxanes(paclitaxel and/or docetaxel)
Eligibility Criteria
Inclusion
- 18-70 years old
- Resistant to enthracycle and taxanes
- Has measurable disease
Exclusion
- Has more than 3 previous chemotherapy regimens
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01143974
Start Date
June 1 2010
End Date
June 1 2012
Last Update
March 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Institute & Hospital. Chinese Academy of Medical Sciences
Beijing, China, 100021